2Salman S, Salman F, Satman I et al. Comparison of acarbose and gliclazideas first-line agents in patients with type 2 diabetes[J]. Curr Med Res Opin, 2001,16(4):296-306.
3Meneilly GS, Ryan EA, Radziuk J.Effect of acarbose on insulin sensitivity in elderly patients with diabetes[J].Diabetes Care,2000,23(8):1162-7.
4Laube H, Linn Th, Heyen P.The effect of acarbose on insulin sensitivity and proinsulin in overweight subjects with impaired glucose tolerance[J]. Exp Clin Endocrinol Diabetes, 1998,106: 231-3.
5Mughal MA, Memon MY, Zardari MK et al. Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes[J].J Pak Med Assoc,2000,50(5):152-6.
6Malaguarnera M, Giugno I, Ruello P et al. Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias[J]. Br J Clin Pharmacol,1999,48:605-9.
7Chiasson JL, Josse RG, Gomis R et al. acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial[J].JAMA,2003,290(4):486-94.
8Ceriello A, Taboga C, Tonutti L et al. Post meal coagulation in diabetes mellitus: the effect of acarbose[J].Diabetologia, 1996,39:469-73.
9Rosenbaum P, Peres RB, Zanella MT, Ferreira SR. Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters[J]. Braz J Med Biol Res, 2002,35(8): 877-84.
10Enc FY, Imeryuz N, Akin L et al. Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release[J]. Am J Physiol Gastrointest Liver Physiol, 2001, 281(3):G752-63.
2Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362:1090-1101.
3Nathan DM.Management hyperglycaemia in type 2 diabetes:a consensus algorithm for initiation and adjustment of therapy[J].Diabetologia,2006,49(8):1711-1721.
4Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med, 2010,362:1090-1101.
